We are pleased to announce that the development of the Android version of FLDApp has been completed.
This application enables simultaneous, non-contact, non-invasive short-term (approximately 10 seconds) measurements of HbA1c, oxygen saturation, and pulse rate. It will first be released on Samsung’s Galaxy series (the range of supported devices is expected to expand). The decision to initially release with Samsung is due to its high global market share, comparable to that of Apple.
The release is planned through the “SFM App Store,” where development is nearly complete.
We aim to launch by the end of September 2025. We will provide further details regarding device limitations, release timing, and methods as much as possible.
